Higher is not better


Hey Reader, Dr Karl here.

Higher is not always better, but too low is most common.
The marker where both ends raise your mortality

IGF-1 is not a score.
It is an instruction.
​
Growth hormone leaves the pituitary, reaches the liver,
and the liver answers by producing IGF-1.
That IGF-1 then goes out to bone, to muscle, to the brain, to the heart, and fat cells as well ... and to every cell in your body with the same message:
build, repair, divide, do not die yet
. You can see why people assume more is better.
​
Growth sounds like youth.
It is not that simple, and the mortality data is not ambiguous about it. A meta-analysis of nineteen separate studies (referenced below) just under thirty-one thousand people,
found the relationship between IGF-1 and all-cause mortality is U-shaped.
​
​Low IGF-1 carried a thirty-three percent higher risk of death
​
compared to the middle.
High (OUT OF RANGE) IGF-1 had a twenty-three percent higher risk.
The lowest-mortality band landed at roughly 120 to 160 ng/mL.
A separate analysis of nearly 381,000 people in the UK Biobank found the same U shape.

Both ends. Not one.
Judi's's IGF-1 in 2008 was 254, at age 53.
That sits out on the right arm of that curve, in the half almost nobody worries about,
because almost everybody has been taught to worry about low.
​
Today, at 71, she runs 137. That sits inside the trough, the ideal middle.
I want to be careful about what that does and does not prove. I am not going to tell you surgery normalized her number, because nobody drew an IGF-1 after her operation. That test was never ordered either. What I will tell you is this. When her 254 came back in 2008, not one of the three physicians who saw it had any idea what it meant, and the reason is that the printed reference range on a lab sheet does not tell you where the risk lives. It tells you where the middle 95 percent of some population sits. Those are different questions.
​
Do you know your IGF-1 number? Most people have never had it run once.

Here's the full story:

To your health and longevity,

Dr. Karl Goldkamp
Keto Naturopath

Become a client. It's life changing coaching ​

Link to our books

Salamander Bay LLC

Read more from Salamander Bay LLC

Hey Reader, Dr Karl here. Six doors, one opened. The scanner existed the whole time. Six specialists saw my wife between 2008 and 2013. Five of them referred her onward. Not one of them ordered an image until the sixth. Here is the sequence. A Naturopathic Doctor recommended two tests to ask her doctor for:IGF-1 and growth hormone.Her gynecologist orders the only the first one but not the second. The IGF-1 comes back very high at 254. She cannot interpret it, and refers on. An endocrinologist...

Hey Reader, Dr Karl here. What I think is happening, and what I cannot prove.I ruled things out before I landed anywhere. Was her blood sugar getting worse? No. Glucose fell 16 points over the four years and direct monitoring agreed. Was she iron deficient, which genuinely does distort A1c? No. Serum iron fell from 105 to 85, but ferritin nearly doubled, 160 to 288. That is not depletion. Was it a lipid shift? No. HDL went 58, 63, 76, 64. It wandered and came back. It cannot explain a...

Hey Reader, Dr Karl here. The chart says her average glucose was 117 to 137Here's what happens when the formula meets the actual measurement. There is a chart in every endocrinology office that converts your A1c into an estimated average glucose. It is printed on lab reports. It gets quoted back to patients as though it were a measurement. A person with an A1c reading of 5.7 to 6.4, that chart says your average glucose should be between 117 and 137 mg/dL. Assumed equivalence between A1c and...